Breast Cancer Risk Elevated With Levonorgestrel-Releasing Intrauterine System Use
FRIDAY, Oct. 18, 2024 (HealthDay News) — Women using levonorgestrel-releasing intrauterine systems (LNG-IUS) have an increased risk for breast cancer, accordin
FRIDAY, Oct. 18, 2024 (HealthDay News) — Women using levonorgestrel-releasing intrauterine systems (LNG-IUS) have an increased risk for breast cancer, accordin
The sequel starring Denzel Washington, Paul Mescal and Pedro Pascal opens in theaters on Nov. 22.
This JAMA issue focuses on important contemporary issues in ethics and medical research and is anchored by 2 Special Communications with their accompanying Viewpoints and…
This JAMA Patient Page describes the autoimmune disease systemic lupus erythematosus and its symptoms, diagnosis, treatment, and prognosis.
AI is transforming the practice of medicine and education in myriad ways. Advances in AI are impacting not only how we work in medical education,…
The Federal Trade Commission finalized changes to a rule that will require healthcare companies to provide more information to regulators ahead of merger and acquisition…
Incorporating brentuximab vedotin into the treatment of advanced-stage classic Hodgkin’s lymphoma improves outcomes in adult and pediatric patients. However, brentuximab vedotin increases the toxic…
This Viewpoint discusses significant revisions in the Declaration of Helsinki in response to changing ethical norms and technologies.
Background Long COVID, also known as post-acute sequelae of COVID-19 (PASC), is a poorly understood condition with symptoms across a range of biological domains that…
This Viewpoint explores the 2024 update to the Declaration of Helsinki from the perspective of the Americas and how countries in this region can implement…
A new study led by Stanford Medicine scientists found that certain changes in neural activity predicted which patients would benefit from a type of cognitive…